$GNW

JPMorgan Chase & Co. Cuts Stock Position in Genworth Financial, Inc. $GNW

JPMorgan Chase & Co. has reduced its stake in Genworth Financial, Inc. by 32.1% in the third quarter, selling over 545,000 shares, although it still holds 1.15 million shares valued at $10.24 million. Despite this reduction, other institutional investors have increased their positions in GNW, with overall institutional ownership at 81.85%. Genworth Financial is currently trading around $7.99, has a "Moderate Buy" consensus rating from analysts with an average price target of $10.50, and recently missed its quarterly EPS estimate.

Original reporting
MarketBeat · MarketBeat
Published Mar 29, 2026, 9:24 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 29, 2026, 10:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
JPMorgan Chase & Co. Cuts Stock Position in Genworth Financial, Inc. $GNW — source image
Decision brief

The 30-second read

$GNWNeutralMed
01

Why it matters

The reduction by JPMorgan Chase signals a cautious stance from a major institutional player, which could influence market perception. However, increased holdings by other institutions mitigate some negative sentiment. The stock's current valuation remains attractive relative to analyst targets, but investor caution is warranted due to insider activity.

02

Market read

The news highlights internal trading activity and analyst ratings, which are relevant for short-term trading decisions but have limited impact on broader market trends.

03

What to watch

Potential upcoming earnings report or macroeconomic developments could influence GNW's stock performance beyond current insider activity.

Timing: short to medium term (next 1-3 months)

Background

JPMorgan Chase reduced its holdings in GNW by 32.1% in Q1, selling over 545,000 shares, yet still holds 1.15 million shares valued at approximately $10.24 million. Other institutional investors increased their positions, leading to an overall institutional ownership of 81.85%. GNW's stock is trading around $7.99, with analyst consensus indicating a 'Moderate Buy' and a target price of $10.50. The company recently missed quarterly EPS estimates.

Company-level read

Ticker impact

$GNWNeutralMedium confidence
Context

The news directly impacts Genworth Financial due to insider trading activity and analyst ratings.

Expected impact

Potential short-term decline followed by stabilization or slight recovery; long-term outlook remains cautiously optimistic.

Evidence & confidence

The mixed institutional activity suggests uncertainty. The stock's current valuation and analyst ratings support a moderate buy stance, but insider selling warrants caution.

Market effects

The insurance and financial services sector may experience slight volatility due to institutional trading activities in GNW.

Limited regional impact; primarily affects North American markets.

Low; GNW's influence on global markets is minimal, but sector-wide sentiment could be mildly affected.

Counterpoint

The insider selling might be routine portfolio rebalancing and not indicative of a negative outlook; institutional holdings could be stabilizing.

Key entities

  • JPMorgan Chase & Co.

    A leading global financial services firm involved in the insider trading activity.

  • Genworth Financial, Inc.

    An insurance company with a focus on mortgage insurance and long-term care insurance.

Related articles

$GNWMed

GENWORTH FINANCIAL INC (GNW): Results of Operations and Financial Condition

GENWORTH FINANCIAL INC (GNW) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 quarterlyearningsrelease.htm EX-99.1 Document Exhibit 99.1 Genworth Financial Announces Second Quarter 2026 Results Strategic Highlights • Strong capital returns from Enact, with $103M received in the quarter • Repurchased $62M of shares in the quarter; $918M since prog

$RKLBMedAI 8/10

Rocket Lab Just Unveiled a Game-Changing Technology Worth Watching

Rocket Lab (RKLB) said it won a $397 million U.S. Space Force contract to develop, launch, and operate multiple Flatellites for the SB-AMTI program. Flatellites are slimmer, stackable satellites intended to increase deployments per launch and integrate with Rocket Lab’s Neutron rocket. The article cites analyst forecasts for revenue rising from $602M (2025) to $1.7B (2028).